Daiwa Securities Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14K | Buy |
429
+40
| +10% | +$1.31K | ﹤0.01% | 1107 |
|
2025
Q1 | $16K | Hold |
389
| – | – | ﹤0.01% | 1078 |
|
2024
Q4 | $18K | Sell |
389
-45
| -10% | -$2.08K | ﹤0.01% | 1089 |
|
2024
Q3 | $23K | Hold |
434
| – | – | ﹤0.01% | 1094 |
|
2024
Q2 | $24K | Buy |
434
+53
| +14% | +$2.93K | ﹤0.01% | 1122 |
|
2024
Q1 | $27K | Hold |
381
| – | – | ﹤0.01% | 1119 |
|
2023
Q4 | $32K | Hold |
381
| – | – | ﹤0.01% | 1092 |
|
2023
Q3 | $11K | Hold |
381
| – | – | ﹤0.01% | 1116 |
|
2023
Q2 | $12K | Hold |
381
| – | – | ﹤0.01% | 1123 |
|
2023
Q1 | $13K | Hold |
381
| – | – | ﹤0.01% | 1085 |
|
2022
Q4 | $17K | Buy |
381
+62
| +19% | +$2.77K | ﹤0.01% | 1083 |
|
2022
Q3 | $15K | Hold |
319
| – | – | ﹤0.01% | 1101 |
|
2022
Q2 | $13K | Buy |
319
+74
| +30% | +$3.02K | ﹤0.01% | 1123 |
|
2022
Q1 | $9K | Hold |
245
| – | – | ﹤0.01% | 1137 |
|
2021
Q4 | $11K | Sell |
245
-41
| -14% | -$1.84K | ﹤0.01% | 1138 |
|
2021
Q3 | $10K | Buy |
286
+153
| +115% | +$5.35K | ﹤0.01% | 1135 |
|
2021
Q2 | $3K | Hold |
133
| – | – | ﹤0.01% | 1102 |
|
2021
Q1 | $3K | Hold |
133
| – | – | ﹤0.01% | 1102 |
|
2020
Q4 | $3K | Sell |
133
-230
| -63% | -$5.19K | ﹤0.01% | 1078 |
|
2020
Q3 | $8K | Hold |
363
| – | – | ﹤0.01% | 1046 |
|
2020
Q2 | $4K | Hold |
363
| – | – | ﹤0.01% | 1101 |
|
2020
Q1 | $4K | Hold |
363
| – | – | ﹤0.01% | 1102 |
|
2019
Q4 | $4K | Hold |
363
| – | – | ﹤0.01% | 1111 |
|
2019
Q3 | $4K | Hold |
363
| – | – | ﹤0.01% | 1074 |
|
2019
Q2 | $4K | Buy |
363
+65
| +22% | +$716 | ﹤0.01% | 1098 |
|
2019
Q1 | $2K | Hold |
298
| – | – | ﹤0.01% | 1116 |
|
2018
Q4 | $2K | Hold |
298
| – | – | ﹤0.01% | 1089 |
|
2018
Q3 | $3K | Hold |
298
| – | – | ﹤0.01% | 1087 |
|
2018
Q2 | $2K | Hold |
298
| – | – | ﹤0.01% | 1123 |
|
2018
Q1 | $2K | Buy |
+298
| New | +$2K | ﹤0.01% | 1114 |
|